Endovascular Intervention for Peripheral Artery Disease

A special issue of Journal of Cardiovascular Development and Disease (ISSN 2308-3425). This special issue belongs to the section "Cardiovascular Clinical Research".

Deadline for manuscript submissions: 31 May 2024 | Viewed by 1775

Special Issue Editors


E-Mail
Guest Editor
Department for Angiology, Cardioangiologisches Center Bethanien, 60389 Frankfurt, Germany
Interests: interventional treatment of PAOD; interventional treatment of venous thrombosis and pulmonary thromboembolism; assessing feasibility, safety and efficacy of endovascular devices; antiplatelet and anticoagulative management during endovascular procedures

E-Mail Website
Guest Editor
Medical Department V – Angiology, University of Leipzig Medical Center, 04103 Leipzig, Germany
Interests: endovascular therapy; PAOD; critical limb ischemia; peripheral artery chronic total occlusion; endovascular aneurysm repair

Special Issue Information

Dear Colleagues,

Recent developments in the treatment of peripheral artery disease (PAD) have focused on endovascular procedures, which are invasive treatment options to improve blood flow in affected vessels.

Significant advances have been made in the endovascular treatment of PAD and the improvement of long-term patency with the development of dedicated stents, drug-eluting devices (stents and balloons), lithotripsy and atherectomy.

However, there remain unmet needs in the optimization of long-term patency in long and calcified lesions. Patient selection, lesion-adjusted device selection, intraprocedural vessel imaging and also the medical concomitant treatment after endovascular procedures and patient education have yet to receive genuine scholarly attention. Additionally, the ongoing question of how to determine whether a patient is more suited to interventional treatment, bypass surgery or conservative treatment remains unanswered.

Overall, ongoing research and development in endovascular procedures for PAD are focused on improving patient outcomes, reducing complications, reducing healthcare costs and identifying the best treatment approaches for different patient populations.

Dr. Michael Piorkowski
Dr. Andrej Schmidt
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • peripheral arteriosclerotic occlusive disease
  • interventional therapy
  • stent
  • drug-eluting therapy
  • debulking
  • atherectomy

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

10 pages, 1697 KiB  
Article
The Influence of Individualized Three-Dimensional Holographic Models on Patients’ Knowledge Qualified for Intervention in the Treatment of Peripheral Arterial Disease (PAD)
by Patryk Skórka, Michał Kargul, Diana Seemannová, Bartosz Gajek, Piotr Gutowski, Arkadiusz Kazimierczak and Paweł Rynio
J. Cardiovasc. Dev. Dis. 2023, 10(11), 464; https://doi.org/10.3390/jcdd10110464 - 15 Nov 2023
Viewed by 1478
Abstract
We sought to determine the role of the patient-specific, three-dimensional (3D) holographic vascular model in patient medical knowledge and its influence on obtaining a more conscious informed consent process for percutaneous balloon angioplasty (PTA). Patients with peripheral arterial disease who had been scheduled [...] Read more.
We sought to determine the role of the patient-specific, three-dimensional (3D) holographic vascular model in patient medical knowledge and its influence on obtaining a more conscious informed consent process for percutaneous balloon angioplasty (PTA). Patients with peripheral arterial disease who had been scheduled for PTA were enrolled in the study. Information regarding the primary disease, planned procedure, and informed consent was recorded in typical fashion. Subsequently, the disease and procedure details were presented to the patient, showing the patients their individual model. A patient and medical supervisor equipped with mixed reality headsets could both simultaneously manipulate the hologram using gestures. The holographic 3D model had been created on a scale of 1:1 based on computed tomography scans. The patient’s knowledge was tested by the completion of a questionnaire before and after the interaction in a mixed reality environment. Seventy-nine patients manipulated arterial holograms in mixed reality head-mounted devices. Before the 3D holographic artery model interaction, the mean ± standard deviation score of the knowledge test was 2.95 ± 1.21 points. After the presentation, the score had increased to 4.39 ± 0.82, with a statistically significant difference (p = 0.0000) between the two scores. Using a Likert scale from 1 to 5, the patients had scored the use of the 3D holographic model at 3.90 points regarding its usefulness in comprehending their medical condition; at 4.04 points regarding the evaluation of the holograms as helpful in understanding the course of surgery; and rated the model at 1.99 points in reducing procedure-related stress. Using a nominal scale (know or don’t know), the patients had self-assessed their knowledge of the procedure before and after the 3D model presentation, with a score of 6.29 ± 2.01 and 8.39 ± 1.54, respectively. The study group tolerated the use of head-mounted devices. Only one patient had nausea and dizziness, while four patients experienced transient eye pain. The 3D holographic arterial model aided in the understanding of patients’ knowledge regarding the disease and procedure, making the informed consent process more conscious. The holograms improved the patient’s self-consciousness. Mixed reality headset-related complications were rare and within acceptable rates. Full article
(This article belongs to the Special Issue Endovascular Intervention for Peripheral Artery Disease)
Show Figures

Figure 1

Back to TopTop